ANDA 87663, held by Ascot. Propantheline Bromide.
As of Nov 15, 2026, ANDA 87663 (Propantheline Bromide), held by Ascot, was not approved, with 1 approved supplement and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Propantheline Bromide15MG ยท tablet;oral | Propantheline Bromide | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 18, 1983 | Supplement 1Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
